Disc Medicine Inc logo

Disc Medicine Inc

IRON
Healthcare|Biotechnology|USA
$76.59
-2.32 (-2.94%)
Tangible Book
$18.03
Earnings Power
$18.04

About

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Stock Price

+32.1%(1Y)

Pipeline Summary

11 total trials
5
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
AVAILABLE: 1Completed: 4ENROLLING_BY_INVITATION: 1Recruiting: 4Active: 1

Active Trials (5)

Study of DISC-0974-201 in Participants With IBD and Anemia
NCT07368972Inflammatory Bowel Disease (IBD)
Phase 2Recruiting
Enrollment: 21 participants
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
NCT06910358Erythropoietic Protoporphyria (EPP)
Phase 3Active
Enrollment: 183 participants
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
NCT07187973Sickle Cell Disease
Phase 1Recruiting
Enrollment: 24 participants
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
NCT05320198Myelofibrosis; Anemia
Phase 1Phase 2Recruiting
Enrollment: 150 participants
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
NCT06985147Polycythemia Vera (PV)
Phase 2Recruiting
Enrollment: 60 participants

BioScore

5.4/10
Watchlist

Ownership

Recent Insider Trades

Yu Jonathan Yen-WenSELL
2026-07-07100 shares @ $82.5
Khara RahulSELL
2026-06-292,500 shares @ $75
Yu Jonathan Yen-WenSELL
2026-06-26300 shares @ $72.5
Yu Jonathan Yen-WenSELL
2026-06-229,700 shares @ $72.66
Khara RahulSELL
2026-06-187,500 shares @ $70.22

Recent News

2026-07-10 08:00:02
2026-06-29 23:00:03
2026-06-19 19:00:02
2026-06-18 18:00:13
2026-06-16 14:02:27
Data last updated: Jul 13, 2026, 12:42 PM